Home
Search
Events

BIO CEO & Investor Conference

Feb 10-11, 2020・New York, New York
Accelerate Discovery. Amplify Returns.
Register

Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private biotech companies. Experience the best of biotech with two days of productive partnering meetings with institutional and early-stage investors, industry analysts, and senior biotechnology executives, in one location.

Partner with Top Investors

Over 340 investors have already registered, including ARCH Venture Partners, New Enterprise Associates, Sofinnova Ventures, and SR One, who are currently active in the partnering system and read to meet! Partnering activity is breaking records, with total meeting requests up 36% and accepted requests pacing 23% ahead of 2019.

View Sample Attendee List
Partnering Blog ScreenGrab_blogsidecard
CEO 2020 Pre Event Planner
Program Highlights

This year’s panelists represent the industry’s who’s who of business thought leaders, clinical innovators and financial market experts. Session topics will cover advances in gene, liver, and cardiovascular disease therapies, developing an inclusive workforce, the global economy (policy and market outlooks).

Download Planner
Featured Registration Packages
Company Presentation + Partnering
Starting at: $1,650  

What's Included: 

  • BIO One-on-One Partnering
  • 13-minute presentation to showcase your pipeline
  • Full programming: Panels and Fireside Chats
  • Welcome reception
  • Conference meals and coffee service
View Packages
Partnering Registration
Starting at: $1,000  

 

What's Included: 

  • BIO One-on-One Partnering
  • Full programming: Panels and Fireside Chats
  • Welcome reception
  • Conference meals and coffee service
View Packages
Last Chance to Apply to Present

Approximately 150 companies have been hand-selected to showcase their pipelines, licensing and investment goals, including Newron Pharmaceuticals, XyloCor Therapeutics, Anima Biotech, and Greenwich LifeSciences, plus our Buzz of BIO winners: Breakthrough Genomics, AZTherapies, and Brainstorm Cell Therapeutics. View them here.

Apply to Present
Featured Speakers
Amy Abernethy
Amy P. Abernethy, MD, PhD
PRINCIPAL DEPUTY COMMISSIONER OF FOOD AND DRUGS, FDA
As the Principal Deputy Commissioner of Food and Drugs, Dr. Amy P. Abernethy, M.D., Ph.D., helps oversee the agency’s day-to-day functioning and…
Michael Morrissey
Michael M. Morrissey, PhD
PRESIDENT AND CHIEF EXECUTIVE OFFICER , EXELIXIS
Michael M. Morrissey, Ph.D., is President and Chief Executive Officer at Exelixis and a member of the Board of Directors. Under Dr. Morrissey’s…
Ted Love
Ted W. Love, MD
PRESIDENT AND CHIEF EXECUTIVE OFFICER, GLOBAL BLOOD THERAPEUTICS
Dr. Love joined GBT in June 2014 as president and chief executive officer with broad leadership and management experience in the biotech…
Amy Abernethy
Michael Morrissey
Ted Love
View all Speakers

See What Happened in 2019

Video still from CEO 2019
Thank You to Our 2020 Sponsors
View All Sponsors